Antimicrobial activity of ceftolozane/tazobactam, imipenem/relebactam, and comparators against Gram-negative pathogens collected in Arabian Gulf countries: SMART 2020-2024.
Saved in:
| Title: | Antimicrobial activity of ceftolozane/tazobactam, imipenem/relebactam, and comparators against Gram-negative pathogens collected in Arabian Gulf countries: SMART 2020-2024. |
|---|---|
| Authors: | Wise MG; IHMA, Schaumburg, IL, United States., Alekseeva I; MSD, Dubai, United Arab Emirates., Siddiqui F; Merck & Co., Inc., Rahway, NJ, United States., Young K; Merck & Co., Inc., Rahway, NJ, United States., Motyl MR; Merck & Co., Inc., Rahway, NJ, United States., Sahm DF; IHMA, Schaumburg, IL, United States. |
| Source: | Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2026 May 12; Vol. 16, pp. 1827575. Date of Electronic Publication: 2026 May 12 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101585359 Publication Model: eCollection Cited Medium: Internet ISSN: 2235-2988 (Electronic) Linking ISSN: 22352988 NLM ISO Abbreviation: Front Cell Infect Microbiol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
